We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+4.6%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$775M
AUM Growth
+$45M
Cap. Flow
+$16.6M
Cap. Flow %
2.15%
Top 10 Hldgs %
29.41%
Holding
331
New
16
Increased
110
Reduced
76
Closed
9

Top Buys

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$4.59M
2
SPLK
Splunk Inc
SPLK
+$2.19M
3
OKE icon
Oneok
OKE
+$1.76M
4
AABA
Altaba Inc
AABA
+$1.61M
5
TXN icon
Texas Instruments
TXN
+$1.37M

Top Sells

Rank Stock Value
1
OKS
Oneok Partners LP
OKS
+$1.84M
2
GE icon
GE Aerospace
GE
+$1.33M
3
YHOO
Yahoo Inc
YHOO
+$1.1M
4
MJN
Mead Johnson Nutrition Company
MJN
+$1.07M
5
CSCO icon
Cisco
CSCO
+$539K

Sector Composition

Rank Sector Weight
1 Healthcare 22.43%
2 Industrials 15.89%
3 Consumer Staples 10.03%
4 Technology 9.7%
5 Financials 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTC icon
26
Intel
INTC
$466B
$6.93M 0.89%
205,456
-1,130
-0.5% -$40.4K
MMP
27
DELISTED
Magellan Midstream Partners, L.P.
MMP
$6.44M 0.83%
90,292
+6,250
+7% +$459K
WMT icon
28
Walmart Inc
WMT
$871B
$6.09M 0.79%
241,479
– –
IBM icon
29
IBM
IBM
$202B
$5.95M 0.77%
40,426
+2,007
+5% +$303K
GILD icon
30
Gilead Sciences
GILD
$161B
$5.88M 0.76%
83,092
+8,067
+11% +$537K
NSC icon
31
Norfolk Southern
NSC
$78.8B
$5.83M 0.75%
47,943
+39,032
+438% +$4.59M
RTX icon
32
RTX Corp
RTX
$287B
$5.68M 0.73%
73,963
+79
+0.1% +$5.92K
TMO icon
33
Thermo Fisher Scientific
TMO
$211B
$5.62M 0.73%
32,223
-228
-0.7% -$38.3K
ACAD icon
34
Acadia Pharmaceuticals
ACAD
$4.25B
$5.49M 0.71%
196,780
+13,130
+7% +$391K
PFE icon
35
Pfizer
PFE
$140B
$5.43M 0.7%
170,323
-12,816
-7% -$404K
XOM icon
36
ExxonMobil
XOM
$651B
$5.34M 0.69%
66,148
-2,132
-3% -$174K
MRK icon
37
Merck
MRK
$324B
$5.22M 0.67%
85,437
– –
EPD icon
38
Enterprise Products Partners
EPD
$83.8B
$5.19M 0.67%
191,717
+8,090
+4% +$219K
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$121B
$4.78M 0.62%
37,070
-300
-0.8% -$36.1K
HYG icon
40
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$4.76M 0.61%
53,842
+1,119
+2% +$98.5K
MO icon
41
Altria Group
MO
$122B
$4.69M 0.61%
63,037
– –
IBB icon
42
iShares Biotechnology ETF
IBB
$9.31B
$4.57M 0.59%
44,235
+1,152
+3% +$113K
KSU
43
DELISTED
Kansas City Southern
KSU
$4.43M 0.57%
42,330
+50
+0.1% +$4.69K
FDX icon
44
FedEx
FDX
$74.5B
$4.4M 0.57%
20,239
– –
EL icon
45
Estee Lauder
EL
$29B
$4.34M 0.56%
45,234
– –
IYG icon
46
iShares US Financial Services ETF
IYG
$2.13B
$4.29M 0.55%
113,532
+1,608
+1% +$58.5K
CVX icon
47
Chevron
CVX
$388B
$4.21M 0.54%
40,298
+200
+0.5% +$21.2K
CSCO icon
48
Cisco
CSCO
$450B
$4.19M 0.54%
133,723
-16,534
-11% -$539K
AMZN icon
49
Amazon
AMZN
$2.5T
$4.16M 0.54%
85,960
+3,120
+4% +$149K
LOW icon
50
Lowe's Companies
LOW
$116B
$4.16M 0.54%
53,591
+2,200
+4% +$180K
1
2
3 4 5

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Gerald L. Ray & Associates held 331 positions worth $775M, up 6.2% from $730M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gerald L. Ray & Associates's Q2 2017 filing shows 16 new, 110 increased, 76 reduced and 9 closed positions. Its largest new stake was Oneok: 33,968 shares worth $1.77M. The largest sale was Oneok Partners LP, an estimated $1.84M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q2 2017 buy was Oneok: 33,968 shares worth $1.77M.
  • Gerald L. Ray & Associates added most to Norfolk Southern in Q2 2017, an estimated $4.59M increase.
  • Gerald L. Ray & Associates's biggest Q2 2017 reduction was GE Aerospace, cutting an estimated $1.33M.
  • Gerald L. Ray & Associates fully exited Oneok Partners LP in Q2 2017, selling an estimated $1.84M.
  • Gerald L. Ray & Associates's ten largest holdings make up 29% of its $775M portfolio in Q2 2017.
  • Gerald L. Ray & Associates opened 16 new positions and closed 9 in Q2 2017.
  • Gerald L. Ray & Associates's portfolio value rose 6.2% quarter-over-quarter to $775M.

Based on Gerald L. Ray & Associates's 13F filing for Q2 2017, filed 8 Aug 2017.